TRAPPC10
Basic information
Region (hg38): 21:44012309-44106552
Previous symbols: [ "TMEM1" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with microcephaly, short stature, and speech delay (Limited), mode of inheritance: AR
- neurodevelopmental disorder with microcephaly, short stature, and speech delay (Strong), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAPPC10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 67 | 75 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 2 | 67 | 8 | 2 |
Variants in TRAPPC10
This is a list of pathogenic ClinVar variants found in the TRAPPC10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-44012503-T-C | not specified | Likely benign (Apr 07, 2023) | ||
21-44012507-A-G | Neurodevelopmental disorder with microcephaly, short stature, and speech delay | Uncertain significance (-) | ||
21-44012513-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
21-44012521-C-G | not specified | Uncertain significance (Mar 15, 2024) | ||
21-44012522-C-T | not specified | Uncertain significance (Jul 20, 2021) | ||
21-44032130-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
21-44032144-C-T | not specified | Uncertain significance (May 25, 2022) | ||
21-44032177-G-C | TRAPPC10-related disorder | Likely benign (Jun 20, 2023) | ||
21-44052386-A-T | not specified | Uncertain significance (May 04, 2023) | ||
21-44052388-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
21-44052388-G-T | not specified | Uncertain significance (Nov 26, 2024) | ||
21-44052403-A-C | not specified | Uncertain significance (Oct 19, 2024) | ||
21-44052474-C-A | not specified | Uncertain significance (Mar 20, 2023) | ||
21-44055756-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
21-44055855-G-C | not specified | Uncertain significance (Feb 12, 2024) | ||
21-44059134-A-G | not specified | Uncertain significance (Mar 02, 2023) | ||
21-44059158-A-G | not specified | Uncertain significance (Sep 17, 2021) | ||
21-44059208-G-T | not specified | Uncertain significance (Jan 18, 2023) | ||
21-44059211-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
21-44063667-G-A | not specified | Uncertain significance (Nov 29, 2024) | ||
21-44063687-C-T | Neurodevelopmental disorder with microcephaly, short stature, and speech delay | Likely pathogenic (May 23, 2023) | ||
21-44063744-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
21-44074395-A-C | not specified | Uncertain significance (Nov 25, 2024) | ||
21-44074409-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
21-44074445-G-A | not specified | Uncertain significance (May 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRAPPC10 | protein_coding | protein_coding | ENST00000291574 | 23 | 94234 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000631 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.56 | 600 | 718 | 0.836 | 0.0000415 | 8277 |
Missense in Polyphen | 111 | 208.47 | 0.53246 | 2400 | ||
Synonymous | -0.111 | 312 | 310 | 1.01 | 0.0000217 | 2446 |
Loss of Function | 6.63 | 7 | 64.4 | 0.109 | 0.00000331 | 734 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000469 | 0.0000462 |
European (Non-Finnish) | 0.0000709 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in vesicular transport from endoplasmic reticulum to Golgi.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Rab regulation of trafficking;RAB GEFs exchange GTP for GDP on RABs;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.143
Intolerance Scores
- loftool
- 0.240
- rvis_EVS
- -1.59
- rvis_percentile_EVS
- 3.12
Haploinsufficiency Scores
- pHI
- 0.317
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.647
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.518
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trappc10
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; skeleton phenotype;
Gene ontology
- Biological process
- intra-Golgi vesicle-mediated transport;early endosome to Golgi transport;COPII vesicle coating;protein complex oligomerization
- Cellular component
- Golgi membrane;cytosol;TRAPP complex;TRAPPII protein complex
- Molecular function
- protein binding;Rab guanyl-nucleotide exchange factor activity